These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20233324)
1. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study. Borelli V; Marchioli A; Di Taranto R; Romano M; Chiandussi S; Di Lenarda R; Biasotto M; Zabucchi G Oral Dis; 2010 May; 16(4):365-74. PubMed ID: 20233324 [TBL] [Abstract][Full Text] [Related]
2. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines. Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome. Zidverc-Trajkovic J; Stanimirovic D; Obrenovic R; Tajti J; Vécsei L; Gardi J; Németh J; Mijajlovic M; Sternic N; Jankovic L J Oral Pathol Med; 2009 Jan; 38(1):29-33. PubMed ID: 19192048 [TBL] [Abstract][Full Text] [Related]
4. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome. Suh KI; Kim YK; Kho HS Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923 [TBL] [Abstract][Full Text] [Related]
5. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile. de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895 [TBL] [Abstract][Full Text] [Related]
6. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Hershkovich O; Nagler RM Arch Oral Biol; 2004 Jul; 49(7):515-22. PubMed ID: 15126133 [TBL] [Abstract][Full Text] [Related]
8. [Role of total IgE in unspecified burning oral symptoms. Serum and salivary comparative levels in a case-control study]. Campisi G; Di Liberto C Minerva Stomatol; 2003; 52(7-8):381-91. PubMed ID: 14608259 [TBL] [Abstract][Full Text] [Related]
9. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study. Amenábar JM; Pawlowski J; Hilgert JB; Hugo FN; Bandeira D; Lhüller F; Lopes de Souza MA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):460-5. PubMed ID: 18329582 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Srinivasan M; Kodumudi KN; Zunt SL Clin Immunol; 2008 Jan; 126(1):31-7. PubMed ID: 17916440 [TBL] [Abstract][Full Text] [Related]
11. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome. Boras VV; Brailo V; Lukac J; Kordić D; Blazić-Potocki Z Oral Dis; 2006 May; 12(3):353-5. PubMed ID: 16700748 [TBL] [Abstract][Full Text] [Related]
12. Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study. Dias Fernandes CS; Salum FG; Bandeira D; Pawlowski J; Luz C; Cherubini K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):537-43. PubMed ID: 19778740 [TBL] [Abstract][Full Text] [Related]
13. Sialochemical and gustatory analysis in patients with oral sensory complaints. Nagler RM; Hershkovich O J Pain; 2004 Feb; 5(1):56-63. PubMed ID: 14975379 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus. Shah B; Ashok L; Sujatha GP Indian J Dent Res; 2009; 20(3):288-92. PubMed ID: 19884710 [TBL] [Abstract][Full Text] [Related]
15. Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome. Pekiner FN; Demirel GY; Gümrü B; Ozbayrak S J Oral Pathol Med; 2008 Oct; 37(9):528-34. PubMed ID: 18624934 [TBL] [Abstract][Full Text] [Related]
16. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178 [TBL] [Abstract][Full Text] [Related]
17. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Welker P; Grabbe J; Grützkau A; Henz BM Immunology; 1998 Jul; 94(3):310-7. PubMed ID: 9771435 [TBL] [Abstract][Full Text] [Related]
18. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome. Kim HI; Kim YY; Chang JY; Ko JY; Kho HS Oral Dis; 2012 Sep; 18(6):613-20. PubMed ID: 22533537 [TBL] [Abstract][Full Text] [Related]
19. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. Yilmaz Z; Renton T; Yiangou Y; Zakrzewska J; Chessell IP; Bountra C; Anand P J Clin Neurosci; 2007 Sep; 14(9):864-71. PubMed ID: 17582772 [TBL] [Abstract][Full Text] [Related]
20. MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus. Kho HS; Chang JY; Kim YY; Kim Y Arch Oral Biol; 2013 Jul; 58(7):837-42. PubMed ID: 23411403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]